Tempest Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Tempest Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q3 2024.
  • Tempest Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Tempest Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • Tempest Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Tempest Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Tempest Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $0 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $0 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $0 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $0 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2018 $34K $0 -$11K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $45K $0 -$13K -100% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $58K $0 -$9K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $67K $34K +$50K Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 $17K $11K -$81K -88% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $98K $13K -$37K -74% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $135K $9K -$66K -88% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $201K -$16K -$91K -121% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $292K $92K +$92K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $200K $50K +$50K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $150K $75K +$75K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $75K $75K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.